Is your organization’s biggest financial risk hiding in plain sight? In this episode, we move beyond the "wellness conversation" to explore why unmanaged hypertension and diabetes are significant balance-sheet issues for modern corporations. From the high-pressure environments of Canary Wharf to the rapidly accelerating health challenges in Nigeria, cardiovascular disease remains a leading driver of avoidable catastrophic claims, workforce instability, and long-term productivity drag.

We dive deep into the strategic shift required for C-suite leaders and risk managers to move from reactive claims pricing to proactive risk infrastructure. We discuss:

• The Hidden Liability: Why a senior executive’s stroke or a manager’s disability claim is often the first visible signal of unmanaged risk.
• The Workplace as a Control Point: How prolonged sitting, chronic stress, and shift patterns act as corporate risk amplifiers.
• The Financial Logic: A comparison of the low, predictable costs of early detection versus the volatile, catastrophic costs of heart attacks and dialysis.
• Market-Specific Strategies: Tailored approaches for the UK's fragmented health silos and Nigeria's infrastructure challenges.
• Governance & Data: How to integrate blood pressure and glucose tracking into Enterprise Risk Registers and ESG reporting without breaching employee trust.

Whether you are a CFO looking to stabilize insurance premiums or a HR Director protecting your leadership pipeline, this episode provides a blueprint for treating cardiovascular health as a board-level strategic priority.

The silent productivity killer is manageable—but only if you treat it as a risk, not an afterthought.